Get started
Author

Philip Kiely

Observed names: KIELY, PHILIP ROBERT, P. KIELY, P. Kiely, Phil Kiely, Philip R. Kiely
Observed institutions: Royal Children's Hospital, The University of Queensland, The University of Western Australia, Australian Red Cross Lifeblood, UNSW Sydney, Queen Elizabeth II Medical Centre, Monash University
ORCID: 0000-0002-2849-7122
Observed ORCID: 0000-0002-2849-7122
OpenAlex ID: A5043954185
Ex vivo monitoring of human cytomegalovirus‐specific CD8+ T‐cell responses using QuantiFERON®‐CMV
2007 · S. Walker, C. Fazou, et al. · Transplant Infectious Disease · 174
The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world
2000 · H. A. KELLY, D. SIEBERT, et al. · Epidemiology and Infection · 148
PDF
Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus
2005 · C. R. Seed, P. Kiely, et al. · Internal Medicine Journal · 106
Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT
2002 · Clive R. Seed, Anthea Cheng, et al. · Transfusion · 77
Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA
2007 · Angelo R. Margaritis, Stewart M. Brown, et al. · Transfusion · 69
No evidence of a significantly increased risk of transfusion‐transmitted human immunodeficiency virus infection in Australia subsequent to implementing a 12‐month deferral for men who have had sex with men (CME)
2010 · Clive R. Seed, Philip Kiely, et al. · Transfusion · 57
The risk of dengue transmission by blood during a 2004 outbreak in Cairns, Australia
2009 · Clive R. Seed, Philip Kiely, et al. · Transfusion · 51
Infectivity of blood components from donors with occult hepatitis B infection – results from an Australian lookback programme
2014 · C. R. Seed, R. Maloney, et al. · Vox Sanguinis · 49
Improved efficiency of national HIV, HCV, and HTLV antibody testing algorithms based on sequential screening immunoassays
2003 · Clive R. Seed, Angelo R. Margaritis, et al. · Transfusion · 44
Hepatitis B virus nucleic acid amplification testing of A ustralian blood donors highlights the complexity of confirming occult hepatitis B virus infection
2014 · Philip Kiely, Angelo R. Margaritis, et al. · Transfusion · 43
False positive viral marker results in blood donors and their unintended consequences
2018 · Philip Kiely, Veronica C. Hoad, et al. · Vox Sanguinis · 41
Hepatitis E virus RNA in Australian blood donors: prevalence and risk assessment
2017 · V. C. Hoad, C. R. Seed, et al. · Vox Sanguinis · 40
The significance of third‐generation HCV RIBA‐indeterminate, RNA‐negative results in voluntary blood donors screened with sequential third‐generation immunoassays
2004 · Philip Kiely, Deborah Kay, et al. · Transfusion · 37
International review of blood donation nucleic acid amplification testing
2024 · Helen M. Faddy, Carla Osiowy, et al. · Vox Sanguinis · 34
Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk
2017 · Philip Kiely, Manoj Gambhir, et al. · Transfusion Medicine Reviews · 33
PDF
Exposure to hepatitis A virus among blood donors, injecting drug users and prison entrants in Victoria
1997 · N. Crofts, G. Cooper, et al. · Journal of Viral Hepatitis · 33
International Forum on Occult hepatitis B infection and transfusion safety
2019 · Clive R. Seed, Jean‐Pierre Allain, et al. · Vox Sanguinis · 32
Analysis of voluntary blood donors with biologic false reactivity on chemiluminescent immunoassays and implications for donor management
2003 · Philip Kiely, Yvonne Stewart, et al. · Transfusion · 30
Analysis of sample‐to‐cutoff ratios on chemiluminescent immunoassays used for blood donor screening highlights the need for serologic confirmatory testing
2010 · Philip Kiely, Kyall Walker, et al. · Transfusion · 28
PDF
Severe acute respiratory syndrome coronavirus‐2: implications for blood safety and sufficiency
2020 · Philip Kiely, Veronica C. Hoad, et al. · Vox Sanguinis · 24
PDF
Risk of variant Creutzfeldt–Jakob disease transmission by blood transfusion in Australia
2022 · Hamish McManus, Clive R. Seed, et al. · Vox Sanguinis · 22
Can We Improve the Management of Blood Donors With Nonspecific Reactivity in Viral Screening and Confirmatory Assays?
2005 · Philip Kiely, Erica Wood · Transfusion Medicine Reviews · 22
Refining the risk estimate for transfusion‐transmission of occult hepatitis B virus
2016 · C. R. Seed, P. Kiely, et al. · Vox Sanguinis · 20
Follow‐up of six blood donors highlights the complementary role and limitations of hepatitis C virus antibody and nucleic acid amplification tests
2003 · C. Hyland, C. R. Seed, et al. · Vox Sanguinis · 20
A method for estimating the residual risk of transfusion‐transmitted HBV infection associated with occult hepatitis B virus infection in a donor population without universal anti‐ HB c screening
2013 · C. R. Seed, P. Kiely · Vox Sanguinis · 19
Works count: 60
Citation count: 1,417
H-index: 22
I10-index: 31
Year
Topic
Type